Sierra oncology inc stock

Sierra Oncology Inc is a clinical-stage drug development company. It focuses on the research, development, and commercialization of DNA Damage Response  22 Jan 2020 Sierra Oncology, Inc. (Nasdaq: SRRA), a late-stage drug development company focused on the development and commercialization of  Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Sierra Oncology, Inc. (SRRA) since 2005 are illustrated in Table 1  26 Nov 2019 Sierra Oncology, Inc. - SRRA Stock Chart Technical Analysis for 11-26-2019 Subscribe to My MAIN Channel Here:  18 Nov 2019 Fenwick represented Sierra Oncology, Inc. in its underwritten public offering of Series A convertible preferred stock.

22 Jan 2020 Sierra Oncology, Inc. (SRRA) will effect a one-for-forty (1-40) reverse split of its Common Stock. The reverse stock split will become effective on 

Sierra Oncology is a clinical stage drug development company advancing targeted therapeutics for the treatment of patients with cancer. We are an ambitious oncology-focused company, oriented towards achieving the successful registration and commercialization of our product candidates. Sierra Oncology Inc SRRA - Quotes, Financials, News ... About Sierra Oncology Inc Sierra Oncology, Inc. is a clinical stage drug development company of therapeutics for the treatment of cancer. Sierra Oncology | Targeted Cancer Treatments | Contact Us

Sierra Oncology | Investor Relations - Stock Information

SRRA - Stock quote for SIERRA ONCOLOGY, INC. - MSN Money View the latest SRRA stock quote and chart on MSN Money. Dive deeper with interactive charts and top stories of SIERRA ONCOLOGY, INC.. Sierra Oncology Inc - Company Profile and News - Bloomberg ...